SgK269 Polyclonal Antibody

Rabbit Anti-SgK269 Polyclonal Antibody

Product Specifications

Background

PEAK1 (pseudopodium enriched atypical kinase 1) encodes a non-receptor tyrosine kinase that is a member of the new kinase family three (NFK3) family. In migrating cells, the encoded protein is associated with the actin cytoskeleton and focal adhesions and promotes developing focal adhesion elongation. This protein may play a role in the regulation of cell migration, proliferation and cancer metastasis.

CAS Number

9007-83-4

Product Name Alternative

PEAK1; KIAA2002; Pseudopodium-enriched atypical kinase 1; Sugen kinase 269; Tyrosine-protein kinase SgK269

Gene ID

79834

Accession Number

Q9H792

Reactivity

Human, Mouse

Immunogen

Synthesized peptide derived from the N-terminal region of human SgK269 at AA range: 80-160

Clonality

Polyclonal

Tag

Pseudopodium-enriched atypical kinase 1

Applications

WB, IHC

Purification Method

The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

Concentration

1 mg/ml

Molecular Weight

195kD

Precautions

The product listed herein is for research use only and is not intended for use in human or clinical diagnosis. Suggested applications of our products are not recommendations to use our products in violation of any patent or as a license. We cannot be responsible for patent infringements or other violations that may occur with the use of this product.

Shipping Conditions

Gel pack with blue ice.

Storage Conditions

Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.

Notes

SgK269 Polyclonal Antibody detects endogenous levels of SgK269 protein.

Observed Molecular Weight

195

Formulation

Liquid solution

Buffer pH

Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.

Applications Notes

Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB 1:500-2000; IHC 1:50-300